The Twitter application is seen on a digital device, Monday, April 25, 2022, in San Diego. (AP Photo/Gregory Bull, File)
After a three-year hiatus, Twitter is set to reverse course on its ban of political ads.
In 2019, Twitter and then-CEO Jack Dorsey moved to ban cause-based ads in an effort, in part, to reduce the spread of misinformation and paid advertising for smear campaigns but the bird app could be reversing course under Elon Musk's leadership.
Musk is a self-described advocate for free speech and the move comes as Twitter struggles to become profitable. In 2018, when political ads had a green light, they accounted for less than $3 million of total spending during the U.S. midterm elections. Facebook also enacted limits on political and social issue advertising at the time but reversed its decision in 2021.
Last November, Twitter went through some turmoil when notable companies like Chipotle, General Mills, Pfizer, United Airlines, and others, halted advertising on the platform after Musk's takeover.
Manhattan District Attorney Alvin Bragg filed a federal lawsuit against Rep. Jim Jordan on Tuesday, accusing the Republican of a “transparent campaign to intimidate and attack” him over his prosecution of former President Donald Trump.
Nashville’s governing council voted Monday to send Justin Jones straight back to the Legislature four days after he was expelled for his role in a protest on the state House floor.
The Justice Department is calling a Texas court ruling that would halt approval of the most commonly used method of abortion in the U.S. "extraordinary and unprecedented."
Nashville city councilors will likely appoint Justin Jones to his former seat on Monday while Memphis-area county commissioners will soon announce when they'll meet to fill the vacancy left by the expulsion of Justin Pearson, which Pearson himself is eligible to fill.
Health and Human Services Secretary Xavier Becerra said "Everything is on the table" when asked if he'd recommend that the FDA ignore Friday's ruling to reverse the agency's nearly 23-year-old approval of the medication abortion drug mifepristone.
